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Introduction
operative period the patient needed transfusion of 3 units of B group packed erythrocytes. Blood tacrolimus levels ranged between 8 and 11 ng/ml. On the Several cases of autoimmune haemolytic anaemia have 10th day after transplantation laboratory analysis been reported after transplantation of ABO-minorrevealed haematocrit 10.4%, haemoglobin 5.4 g/dl, incompatible organs [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Antibodies to autologous WBC 35 400/mm3, platelets 232 000/mm3, reticulocytes red blood cells (RBC ) most frequently appeared within 156 000/mm3, lactic dehydrogenase (LDH ) 1906 U/l, the first weeks after transplantation from a O-blood serum haptoglobin 17 mg/dl (normal 40-200 mg/dl ), group donor to an A-, B-, or AB-blood group recipient serum indirect bilirubin 2.8 mg/dl, and direct bilirubin and in the majority of the cases the immunosuppressive 1.3 mg/dl. Free plasma haemoglobin and haemotherapy included cyclosporin [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . To our knowglobinuria were noted. Peripheral blood smear revealed ledge only one case of alloimmune haemolytic anaemia erythrocyte morphology was normochromic and normhas been described after an organ-solid transplantaocytic. All of these findings suggested the diagnosis of tion with ABO incompatibility and under tacrolimus haemolytic anaemia and prompted tacrolimus and therapy [20] .
We present here three cases of alloimmune haemo-azathioprine discontinuation that were replaced by lytic anaemia due to minor ABO incompatibility after mycophenolate mofetil. renal transplantation in two patients treated with Direct antiglobulin tests (DAT ) were positive with tacrolimus and in one patient receiving cyclosporin. anti-IgG and anti-C3d. An eluate prepared from the The pathogenetic mechanisms involved and strategy patient's red cells showed anti-B antibodies. Moreover, for treatment are discussed.
anti-B antibodies were detected in the patient's serum. Studies with dithiothreitol demonstrated that the antibody consisted of IgG. A test to identify a tacro-
Case reports
limus-dependent antibody, which might be implicated in drug-induced hemolysis was negative. Four units of O group packed erythrocytes were transfused. Over Case 1 the following days renal function worsened quickly A 51-year-old man with end-stage renal disease and the patient need dialysis. The blood group of the secondary to nephrosclerosis began continuous ambu-patient changed to O group and the DAT became latory peritoneal dialysis (CAPD) in May 1994. On negative, but anti-B antibodies were still positive. 31 December 1996 he received a cadaveric renal transImmunosuppressive therapy was continued with plantation from a 64-year-old donor. HLA typing of mycophenolate mofetil (2 g/day), methylprednisolone recipient was A1, A2, B8, B35, DR16, DR17, and of (500 mg/day) for 5 days, followed by prednisone (30 mg/day), and OKT-3 (5 mg/day) for 14 days. Two days after the discontinuation of OKT-3 the haemolysis gradually disappeared and 2 weeks later, a new control showed haematocrit 31%, haemoglobin patient presented leukopenia of 800 WBC/mm3. Mycophenolate mofetil was discontinued and changed 10.1 g/dl, WBC 6000/mm3, platelet 146 000/mm3, total bilirubin 1.2 mg/dl, serum creatinine 1.1 mg/dl, and to cyclosporin (7 mg/kg/day), and treatment with granulocyte-colony-stimulating factor (GCSF ) creatinine clearance 88 ml/min. (300 mg/day) was initiated. Ten days later the WBC normalized and GCSF could be stopped. Haemolysis Case 3 persisted unmodified and anti-B antibodies remained A 59-year-old man with end-stage renal disease secondpositive 2 weeks later. The graft was non-functioning ary to interstitial nephropathy initiated CAPD in April and the patient continued to need dialysis and blood 1995. In May 16, 1997 he received a cadaveric renal transfusions. A biopsy taken at the 54th post-operative transplantation from a 42-year-old donor. HLA typing day showed evidence of acute tubular necrosis.
of the recipient was A3, A28, B8, B14, DR17, DR17, On day 62 the patient developed pulmonary asperand of the donor was A1, A2, B8, DR3, DR6. Blood gillosis and was treated with itraconazole 200 mg/day groups of the patient and the donor were A Rh(+) for 3 months. Allograft function was never recovered and O Rh(+) respectively. Initial immunosuppression and immunosuppressive drugs were stopped and the consisted of prednisone (30 mg/day) and tacrolimus patient regressed to CAPD. Subsequent serological (16 mg/day). Graft function was immediate and the evaluation revealed no evidence of haemolysis. He post-operative period was without complications. On remains clinically well on CAPD over 6 months later.
the 10th post-operative day the patient was discharged with haematocrit 30%, haemoglobin 10.3 g/dl, serum Case 2 creatinine 1.7 mg/dl, and creatinine clearance 68 ml/min. Blood tacrolimus levels ranged between A 47-year-old man with end-stage renal disease second-12.3 and 14.1 ng/ml. On the 23rd day after transplantaary to interstitial nephropathy initiated haemodialysis tion laboratory analysis revealed haematocrit 22%, in January 1993. On 13 April 1997 he received a haemoglobin 7.3 g/dl, WBC 11 200/mm3, platelets cadaveric renal transplantation from a 64-year-old 220 000/mm3, reticulocytes 100 000/mm3, LDH 363 woman. HLA typing of recipient was A2, A28, B44, U/l, serum haptoglobin<5 mg/dl, serum indirect bili-B14, DR1, DR15, and of donor was A2, A9, B7, rubin 1.08 mg/dl, and direct bilirubin 0.26 mg/dl. DR4, DR15. Blood groups of the patient and his Peripheral blood smear revealed normal erythrocyte donor were B Rh(+) and O Rh(+), respectively. morphology. The serum creatinine was 1.9 mg/dl and Immunosuppressive therapy consisted of prednisone the creatinine clearance 60 ml/min. (30 mg/day), cyclosporin (7 mg/kg/day) and azathioAt admission to the hospital DAT were positive with prine (1.5 mg/kg/day). He received transfusion of 1 anti-IgG and anti-C3d. An eluate prepared from the unit of B group packed erythrocytes. Graft function patient's red cells showed anti-A antibodies. Moreover, was immediate and the post-operative period was anti-A antibodies were detected in the patient's serum. without complications. In the 10th day the patient
The patient received methylprednisolone (500 mg/day) was discharged with haematocrit 28%, haemoglobin by 3 days, the prednisone dose was continued to 9.4 g/dl, serum creatinine 2 mg/dl, and creatinine 15 mg/day and 1 unit of O group packed erythrocytes clearance 36 ml/min. Blood cyclosporin levels ranged was transfused. The tacrolimus dose was reduced to between 241 and 274 ng/ml (target range 150-14 mg/day while blood trough levels were maintained 200 ng/ml ). between 7 to 10 ng/ml. The signs of haemolysis graduOn the 22nd day after transplantation laboratory ally improved and 5 days after admission he was analysis revealed haematocrit 17.7%, haemoglobin discharged with serum creatinine 1.9 mg/dl. The serum 6.4 g/dl, WBC 14 000/mm3, platelets 187 000/mm3, haptoglobin levels progressively increased to 92 mg/dl reticulocytes 300 000/mm3, LDH 616 U/l, serum haptoin 4 weeks and haemoglobin gradually normalized. globin 20 mg/dl, serum indirect bilirubin 1.4 mg/dl, and direct bilirubin 1.3 mg/dl. Peripheral blood smear revealed normal erythrocyte morphology. The patient Discussion was admitted to the hospital and DAT was positive with anti-IgG. An eluate prepared from the patient's red cells showed anti-B antibodies. Moreover, anti-B Haemolysis has already been reported after transplantation. Some cases are clearly related to haemoantibodies were detected in the patient's serum. The prednisone dose was increased to 60 mg/day during 3 lytic-uraemic syndrome (HUS ) and usually attributed to cyclosporin treatment [21] . HUS has, however, also days and the patient received transfusion of 2 units of O group packed erythrocytes. Prednisone 20 mg/day been described in a patient receiving tacrolimus [22] .
Acute haemolysis has also been related to antiwas continued, and cyclosporin was progressively reduced from the initial dose of 450 mg/day to erythrocyte alloantigens and autoantibodies in some kidney transplant recipients [1-3,5-10,23-25]. In 250 mg/day (3.8 mg/kg/day) while blood trough levels decreased to 158 ng/ml. Five days after admission the most cases patients from blood group A, B, or AB had received an ABO-compatible although ABO-nonpatient was discharged with serum creatinine 1.5 mg/dl and creatinine clearance 57 ml/min. The signs of identical organ, mostly from group O. Haemolysis usually appeared within the first 2 weeks after Immunosuppressive drugs used to prevent rejection, cyclosporin and tacrolimus, are more effective and transplantation and lasted from 2 weeks to several months. In these cases, the haemolysis has been selective, but still induce a marked immunological deficit. Such deficit can be accentuated when additional related to alloantibodies derived from passenger B lymphocytes transplanted together with the organ factors are present, e.g. cytomegalovirus infection, administration of OKT-3, or drug-induced neutropenia [6, 10, 12, 21, [25] [26] [27] [28] . Several such cases have been reported after renal transplantation [10, 12, 24] , (ganciclovir, azathioprine, or mycophenolate mofetil ).
They predispose to the development of GVHD when although it is more common after liver transplantation [20, 26, 27] . The occurrence of this complication, a the patient receives immune competent lymphocytes present in the graft. Since haemolysis has been most form of graft-versus-host disease (GVHD), no doubt reflects the better immunosuppression achieved with frequently related to cyclosporin therapy, some authors have suggested that B lymphocytes were mainly cyclosporin.
Acute haemolytic anaemia has also been reported in allowed to proliferate and to produce antibodies because it inhibits T-cell function and relatively spares patients treated with tacrolimus [20, 29] . In these cases, three mechanisms of haemolysis have been described: B-cell activity [32, 33] . It is hypothesized that cyclosporin prevented the recipient's immune system from drug-induced haemolysis, autoimmune haemolysis, and haemolysis secondary to alloantibodies derived damaging the donor's B lymphocytes and that a subtype of these B-cells, which were also resistant to from passenger lymphocytes contained within the graft [20, 29] .
cyclosporin, produced anti-A and anti-B antibodies [34, 35] . This could be the mechanism of haemolysis in The clinical picture of the patients presented here was completely different from HUS. The existence of case 2. Similarly, in cases 1 and 3 the alloimmune haemolytic anaemia may reflect an analogous phenomsevere anaemia without schistocytosis, indirect hyperbilirubinaemia, increased serum LDH levels and enon in relation to tacrolimus therapy. Therefore, a deep T cell suppression may have played an indirect decreased serum haptoglobin levels in the presence of good graft function suggested in all cases a haemolytic role in producing the alloimmune haemolytic anaemia by permitting the clonal development of donor B anaemia. A striking feature of these patients was the onset of alloimmune haemolysis in the first weeks after lymphocytes in the recipients. The long duration of haemolysis together with the persistence of anti-B transplantation covered by heavy immunosuppressive therapy including tacrolimus or cyclosporin. Two antibodies in case 1 could be favoured by concomitant OKT-3 and ganciclovir therapy. patients were group B positive and one patient group A positive, and all received a group O graft. The DAT No treatment has been proved effective in transplant patients who develop haemolytic anaemia. Although showed that antierythrocyte antibodies responsible of haemolysis were of the IgG isotype. Furthermore, the some cases have responded to high-dose corticosteroids, this therapy has not been uniformly successful. alloantibodies eluted and the antibodies identified in the serum of the three patients had the anti-B or the Other immunosuppressor drugs have been used with little success, perhaps because these agents further anti-A specificity, as would be expected in the passenger lymphocyte syndrome ( Table 1) . Diagnostic certainly compromise the immune system. On the other hand, although in some cases the improvement was related is achieved by the detection of donor HLA antigens in the host bone marrow or peripheral blood (chimerism), to the decrease in immunosuppression, it is also certain that spontaneous remission within 2 months is the or by DNA studies. However, circulating passenger lymphocytes have been shown after transplantation in usual outcome.
In conclusion, optimal management is unknown. a significant percentage of recipients, but their presence would not necessarily indicate that they are producing Prevention is therefore very important to avoid this complication. It could be achieved by avoiding proautoantibodies [30, 31] . Therefore, the immunohaematological evaluation supports alloimmune haemolytic found immunosuppression in the early post-transplant period in patients with higher risk. In situations such anaemia resulting from passenger lymphocyte syndrome in these cases. Moreover, although the severity as that presented here slight adjustment of cyclosporin or tacrolimus dose may be an adequate treatment. of haemolysis in the three cases varied widely, the clinical picture resolved within a few weeks.
Since cyclosporin and tacrolimus are T specific, more 
